A Financial Model to Assist New Therapeutics Development Decision Making
Biotech is an industry that is heavily reliant on the risky Research and Development process. While the biotech projects are most often valued with Discounted Cash Flow (DCF) methods, the risk and the phased development process of the biotech industry make it an ideal process to be valued by a real...
| Հիմնական հեղինակ: | |
|---|---|
| Այլ հեղինակներ: | |
| Ձևաչափ: | Թեզիս |
| Հրապարակվել է: |
Massachusetts Institute of Technology
2022
|
| Առցանց հասանելիություն: | https://hdl.handle.net/1721.1/146682 |